DekaBank Deutsche Girozentrale’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $514K | Hold |
25,000
| – | – | ﹤0.01% | 979 |
|
|
2025
Q1 | $489K | Hold |
25,000
| – | – | ﹤0.01% | 978 |
|
|
2024
Q4 | $628K | Hold |
25,000
| – | – | ﹤0.01% | 958 |
|
|
2024
Q3 | $826K | Hold |
25,000
| – | – | ﹤0.01% | 923 |
|
|
2024
Q2 | $943K | Hold |
25,000
| – | – | ﹤0.01% | 889 |
|
|
2024
Q1 | $1.03M | Hold |
25,000
| – | – | ﹤0.01% | 870 |
|
|
2023
Q4 | $994K | Buy |
+25,000
| New | +$994K | ﹤0.01% | 900 |
|
|
2018
Q3 | – | Sell |
-3,720
| Closed | -$28K | – | 1231 |
|
|
2018
Q2 | $28K | Hold |
3,720
| – | – | ﹤0.01% | 1193 |
|
|
2018
Q1 | $128K | Buy |
+3,720
| New | +$128K | ﹤0.01% | 1033 |
|
|
2016
Q2 | – | Sell |
-3,233
| Closed | -$175K | – | 1002 |
|
|
2016
Q1 | $175K | Sell |
3,233
-107
| -3% | -$5.79K | ﹤0.01% | 868 |
|
|
2015
Q4 | $808K | Buy |
3,340
+33
| +1% | +$7.98K | 0.01% | 597 |
|
|
2015
Q3 | $523K | Buy |
3,307
+167
| +5% | +$26.4K | 0.01% | 682 |
|
|
2015
Q2 | $1.19M | Buy |
3,140
+113
| +4% | +$42.8K | 0.01% | 535 |
|
|
2015
Q1 | $1.27M | Sell |
3,027
-166
| -5% | -$69.4K | 0.02% | 531 |
|
|
2014
Q4 | $871K | Sell |
3,193
-294
| -8% | -$80.2K | 0.01% | 587 |
|
|
2014
Q3 | $678K | Buy |
3,487
+67
| +2% | +$13K | 0.01% | 587 |
|
|
2014
Q2 | $837K | Buy |
3,420
+120
| +4% | +$29.4K | 0.01% | 525 |
|
|
2014
Q1 | $875K | Buy |
3,300
+227
| +7% | +$60.2K | 0.01% | 490 |
|
|
2013
Q4 | $1.08M | Buy |
3,073
+60
| +2% | +$21.1K | 0.02% | 421 |
|
|
2013
Q3 | $1.6M | Buy |
3,013
+80
| +3% | +$42.5K | 0.03% | 350 |
|
|
2013
Q2 | $667K | Buy |
+2,933
| New | +$667K | 0.01% | 425 |
|